Long noncoding RNAs (lncRNAs) are being increasingly recognized as major players in
governing fundamental biological processes through diverse mechanisms. Maternally …

Abstract Maternally expressed gene 3 (MEG3) is suggested to function as a long non-coding
RNA (lncRNA) and to play roles in various human cancers. However, the functional …

Recent advances in genome‐wide analysis have revealed that 66% of the genome is
actively transcribed into noncoding RNAs (ncRNAs) while less than 2% of the sequences …

Cancer cells acquire numerous biological properties (designated “cancer hallmarks”), such
as cell survival and energy metabolism, that facilitate tumor growth and metastatic …

Abnormal lipid metabolism including synthesis, uptake, modification, degradation and
transport has been considered a hallmark of malignant tumors and contributes to the supply …

Long noncoding RNAs (lncRNAs) are emerging as key factors in various fundamental
cellular biological processes, and many of them are likely to have functional roles in …

The advent of techniques such as microarrays and high-throughput sequencing has
revolutionized our ability to examine messenger RNA (mRNA) expression within the …

Background: Long non-coding RNAs (lncRNAs) have been recently observed in various
human cancers. However, the role of lncRNAs in pancreatic duct adenocarcinoma (PDAC) …

LncRNAs are emerging as integral functional and regulatory components of normal
biological activities and are now considered as critically involved in the development of …

Long non-coding RNA MEG3 has been identified as a tumor suppressor which plays
important roles in tumorigenesis; however, its potential role in breast cancer has not been …